Children and adolescents with cystic fibrosis (CF) showed increased oxidative stress, which can cause cellular damage, higher inflammation, and…
Andrea Lobo, PhD
Andrea Lobo holds a Biology degree, and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
A new model based on body composition and hand grip strength may help clinicians identify children with cystic fibrosis…
Trikafta (elexacaftor, tezacaftor, and ivacaftor) may improve blood sugar control in people with cystic fibrosis (CF), including those with…
People with cystic fibrosis (CF) continued to receive less recommended routine CF care through 2023 than they did before…
People with cystic fibrosis (CF) may have altered responses to high temperatures compared with healthy individuals, a study in…
CF-related diabetes (CFRD) patients are able to adhere to their treatment routines, and the condition doesn’t hurt their mental…
MRI images when a patient exhales may help detect and quantify areas presumed to reflect gas trapping — an early…
People with cystic fibrosis (CF) treated with CFTR modulators have a significantly lower risk of death than untreated patients,…
The use of combined hormonal contraceptives by women with cystic fibrosis (CF) who are not taking CFTR modulators increases…
Respiratory symptoms are key drivers for starting Kaftrio (elexacaftor/tezacaftor/ivacaftor) among adults with cystic fibrosis (CF) who have stable, near-normal…